Inavolisib
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for Inavolisib, covering 2024-10-09 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer